Coventry and Alan Buerger Move to Dismiss Abacus Lawsuit
Coventry First LLC and Alan H. Buerger have filed a Motion to Dismiss a lawsuit brought by Abacus Global Management (NASDAQ: ABL) in the U.S. District Court for the Middle District of Florida. The motion argues that Abacus's lawsuit attempts to suppress constitutionally protected debate about life settlement industry practices.
A significant development supporting the motion is that Lapetus Solutions, Abacus's primary life expectancy provider, has ceased all operations as of August 31, 2025. Buerger emphasizes that transparent discussions about life expectancy estimates and industry practices are crucial for investors, regulators, and the overall life settlement market.
Coventry First LLC e Alan H. Buerger hanno depositato una mozione per respingere una causa intentata da Abacus Global Management (NASDAQ: ABL) presso il tribunale distrettuale degli Stati Uniti per il Middle District della Florida. La mozione sostiene che la causa di Abacus mira a soffocare un dibattito costituzionalmente protetto sulle pratiche del settore delle life settlement.
Un elemento significativo a sostegno della mozione 猫 che Lapetus Solutions, principale fornitore di aspettative di vita per Abacus, ha cessato ogni attivit脿 il 31 agosto 2025. Buerger sottolinea che discussioni trasparenti sulle stime di aspettativa di vita e sulle pratiche del settore sono fondamentali per investitori, autorit脿 di regolamentazione e per il mercato delle life settlement nel suo complesso.
Coventry First LLC y Alan H. Buerger han presentado una moci贸n para desestimar una demanda interpuesta por Abacus Global Management (NASDAQ: ABL) ante el Tribunal de Distrito de los Estados Unidos para el Distrito Medio de Florida. La moci贸n argumenta que la demanda de Abacus intenta suprimir un debate constitucionalmente protegido sobre las pr谩cticas de la industria de life settlements.
Un desarrollo significativo que respalda la moci贸n es que Lapetus Solutions, el principal proveedor de esperanza de vida de Abacus, ha cesado todas sus operaciones a partir del 31 de agosto de 2025. Buerger enfatiza que las discusiones transparentes sobre las estimaciones de esperanza de vida y las pr谩cticas del sector son cruciales para los inversores, los reguladores y el mercado de life settlements en general.
Coventry First LLC鞕� Alan H. Buerger電� 頂岆毽嫟 欷戨秬 鞐半癌氩曥洂(U.S. District Court for the Middle District of Florida)鞐� Abacus Global Management (NASDAQ: ABL)臧赌 鞝滉赴頃� 靻岇啞鞚� 旮瓣皝頃� 雼澕電� 霃欖潣(氇厴)毳� 鞝滌稖頄堨姷雼堧嫟. 頃措嫻 霃欖潣靹滊姅 Abacus鞚� 靻岇啞鞚� 靸濍獏氤错棙 鞐瓣笀(霛检澊頂� 靹疙媭毹柬姼) 鞐呹硠 甏�頄夓棎 甏�頃� 項岆矔靸� 氤错樃霅橂姅 雲检潣毳� 鞏奠晻頃橂牑 頃滊嫟瓿� 欤检灔頃╇媹雼�.
霃欖潣毳� 霋冯皼旃晿電� 欷戩殧頃� 靷嫟搿滊姅 Abacus鞚� 欤检殧 靾橂獏(旮半寑靾橂獏) 鞝滉车鞐呾泊鞚� Lapetus Solutions臧赌 2025雲� 8鞗� 31鞚茧秬搿� 氇摖 鞓侅梾鞚� 欷戨嫧頄堧嫟電� 鞝愳澊 鞛堨姷雼堧嫟. Buerger電� 靾橂獏 於旍爼旃橃檧 鞐呹硠 甏�頄夓棎 雽�頃� 韴獏頃� 雲检潣臧赌 韴瀽鞛�, 攴滌牅雼龟淡 氚� 鞝勳泊 霛检澊頂� 靹疙媭毹柬姼 鞁滌灔鞐� 頃勳垬鞝侅澊霛缄碃 臧曥“頃╇媹雼�.
Coventry First LLC et Alan H. Buerger ont d茅pos茅 une requ锚te en nullit茅 d'une plainte intent茅e par Abacus Global Management (NASDAQ: ABL) devant le tribunal de district des 脡tats-Unis pour le Middle District de Floride. La requ锚te soutient que l'action d'Abacus cherche 脿 茅touffer un d茅bat constitutionnellement prot茅g茅 sur les pratiques du secteur des life settlements.
Un 茅l茅ment notable appuyant la requ锚te est que Lapetus Solutions, principal fournisseur des estimations d'esp茅rance de vie d'Abacus, a cess茅 toute activit茅 au 31 ao没t 2025. Buerger souligne que des discussions transparentes sur les estimations d'esp茅rance de vie et les pratiques du secteur sont essentielles pour les investisseurs, les r茅gulateurs et le march茅 des life settlements dans son ensemble.
Coventry First LLC und Alan H. Buerger haben einen Antrag auf Abweisung einer Klage eingereicht, die Abacus Global Management (NASDAQ: ABL) beim U.S. District Court for the Middle District of Florida angestrengt hat. Der Antrag tr盲gt vor, Abacus' Klage ziele darauf ab, verfassungsrechtlich gesch眉tzte Debatten 眉ber Praktiken der Life-Settlement-Branche zu unterdr眉cken.
Ein wichtiger Aspekt, der den Antrag st眉tzt, ist, dass Lapetus Solutions, Abacus' Hauptanbieter von Lebenserwartungsdaten, zum 31. August 2025 alle Aktivit盲ten eingestellt hat. Buerger betont, dass transparente Diskussionen 眉ber Lebenserwartungssch盲tzungen und Branchenpraktiken f眉r Investoren, Regulierungsbeh枚rden und den gesamten Life-Settlement-Markt von zentraler Bedeutung sind.
- None.
- Abacus's key life expectancy provider Lapetus has shut down operations
- Legal challenges and potential litigation costs for the company
Insights
Abacus faces serious operational challenges with primary life expectancy provider's shutdown and defensive litigation strategy backfiring.
The motion to dismiss filed against Abacus Global Management (NASDAQ: ABL) reveals two significant developments with potentially material consequences for the company's operations and investor risk profile.
First and most concerning is the revelation that Lapetus Solutions, characterized as Abacus's "primary life expectancy provider," has completely ceased operations as of August 31. For a life settlement company, accurate life expectancy predictions form the cornerstone of the business model - they directly determine pricing, portfolio valuation, and ultimately profitability. The abrupt shutdown of Abacus's main provider creates immediate operational uncertainty regarding how the company will generate reliable life expectancy estimates moving forward.
Second, the litigation itself appears to be backfiring strategically. Rather than suppressing criticism, Coventry's motion frames Abacus's lawsuit as an attempt to "silence constitutionally protected debate" about legitimate industry concerns. This characterization shifts the narrative from whatever original claims Abacus was making to questions about the company's transparency and corporate governance. The motion explicitly references "serious problems of [Abacus's] own making" - language that suggests potential underlying operational or disclosure issues.
The First Amendment defense presented by Coventry appears strategically sound, as courts typically afford strong protection to speech concerning matters of public interest, particularly in financial markets. The motion indicates this case may ultimately amplify rather than suppress the very criticisms Abacus sought to silence, potentially triggering increased regulatory and investor scrutiny.
Motion underscores that Abacus's claims lack merit as Lapetus, its key life expectancy provider, shut its doors August 31
In the filing, Coventry and Mr. Buerger express their view that Abacus's lawsuit is an effort to silence constitutionally protected debate. As the Motion states:
"The First Amendment expresses 'a profound national commitment to the principle that debate on public issues should be uninhibited, robust, and wide-open.' Abacus, however, seeks to flip that principle on its head. Faced with criticism about serious problems of its own making, Abacus brought this meritless lawsuit to muzzle those who have highlighted the truth or expressed their constitutionally protected opinions. That it cannot do."
The Motion also highlights that Abacus invested in and relied heavily upon Lapetus Solutions, Inc. ("Lapetus") as its primary life expectancy provider 鈥� but Lapetus publicly announced that it shut down all operations effective August 31, 2025. This development underscores the concerns raised regarding Abacus's practices and the importance of open debate about the life settlement industry. 聽
"Abacus's complaint is an attempt to silence robust debate on important issues affecting the life settlement industry, including the reliability of life expectancy estimates," said Mr. Buerger. "Transparent disclosures advance the interests of investors, regulators, and the life settlement market as a whole, and the First Amendment protects the right to voice opinions and concerns, particularly on matters of such public interest."
About Coventry
Coventry is the leader and creator of the secondary market for life insurance. For more than 20 years, we have been driving the industry forward and expanding opportunities for life insurance policyowners. Coventry's deep experience combined with a fierce commitment to consumer rights makes Coventry the clear market leader, a position we use to raise industry standards and expand consumer choice. To date, we have delivered more than
Media Contacts:
Prosek Partners for Coventry
Andy Merrill / Kiki Tarkhan
笔谤辞-颁辞惫别苍迟谤测蔼辫谤辞蝉别办.肠辞尘听
View original content:
SOURCE Coventry
FAQ
What is the lawsuit between Abacus Global Management (NASDAQ: ABL) and Coventry First about?
When did Lapetus Solutions, Abacus's life expectancy provider, cease operations?
What is the significance of Lapetus shutting down for Abacus (NASDAQ: ABL)?
Where was the Motion to Dismiss filed by Coventry and Alan Buerger?
What are the main arguments in Coventry's Motion to Dismiss against Abacus (ABL)?
